The Pediatric Early Development Symposium (PEDS) is dedicated to advancing pediatric cancer drug development through pharmacokinetics, modeling, and improved clinical trial designs.
The Pediatric Early Development Symposium (PEDS) covers topics such as:
- How Pharmacokinetics can Enhance the Design of Your Clinical Trial
- Overview of Concepts and Terminology of Pharmacokinetics
- What are critical elements and practical expectations for the FDA
- Dose-Response Relationship: Step from Animals to Humans Fundamentally Flawed?
- How to/Who Identifies the Minimum Number of Patients Needed in a Trial?
- How do you Operationalize a Trial in the Pediatric Population?
- Keynote: Designing Data with a Focus on Pharmacokinetics and Clinical Trials
- How to Bring a Therapeutic Agent to the Clinic for Kids with Cancer Using Data?
- Breakout Sessions – How Can We Break Down Barriers and Better Solve Problems in Clinical Trials?
- Appropriate Use of Extrapolation and Modeling Data from Adults
- AI/ML: The True Future of Drug Development in Pediatric Oncology
- Advanced Modeling Techniques Enhance Future Drug Development
- Future of Clinical Trials in Children with Cancer: We Must Do Better
The Pediatric Early Development Symposium (PEDS) brings together attendees involved or interested in:
- Clinical Operations
- Late Development
- Academic
- Management/Executives
- Patient Advocates
- Key Opinion Leaders
- Medical Affairs
- Regulators
- Project Management
- Clinical Affairs
- Research and Development
- Regulatory Affairs
- Early Development
